These biotech names are ripe for mergers: Analysts
May 10, 2015 at 11:00 AM EDT
Synageva isn't the only eligible takeout target in biotech. Meg explains who industry analysts are pointing to as the next takeout candidates.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|